{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-027568","form_type":"8-K","ticker":"GTBP","cik":"0000109657","company_name":"GT Biopharma, Inc.","filed_at":"2022-10-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.596087+00:00","generated_at":"2026-06-23T05:30:03.353612+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"GT Biopharma adjourns special shareholders meeting due to lack of quorum; reconvened Oct 10","bullets":["Special meeting on Sept 28 lacked quorum; adjourned to Oct 10, 2022 at 11 a.m. PST.","Record date remains Aug 8, 2022; prior votes count unless changed.","Proposal unchanged: ratify discretionary broker voting on authorized share reduction from 750M to 250M.","Company urges all shareholders to vote by Oct 9 to ensure quorum at reconvened meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-027568","json":"https://secwatch.observer/filing/0001493152-22-027568.json","markdown":"https://secwatch.observer/filing/0001493152-22-027568.md","text":"https://secwatch.observer/filing/0001493152-22-027568.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/109657/000149315222027568/0001493152-22-027568-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/109657/000149315222027568/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T05:30:03.353612+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}